GSK Ireland information about our respiratory portfolio, as well as resources and latest news.
This browser is no longer supported.
To provide you with the best possible experience, we kindly ask you to switch to a supported browser:
GSK's primary therapy areas
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
L.M. Last updated November 2021 PM-IE-NA-WCNT-210024